VHT holdings

Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 100% at a quoted market price (level 1), one issuer country.

VHT's largest investment is ELI Lilly & Co at 14.04% of net assets. Johnson&johnson and Abbvie Inc follow; the three together are 28.6%. Ten companies are 51.95% of the fund; the other 393 share the rest. Among the 721 equity funds measured here, VHT behaves like 23 holdings against a median of 42.4 — 1.9 times more concentrated than the median. Across 27 quarterly filings VHT has become more concentrated: it behaved like 37.3 at 2019-11-30 and 23 at 2026-05-31. Between the 2026-02-28 and 2026-05-31 filings 3 positions were added and 12 dropped; 6.9% of the weight moved.

Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.

Between 2019-11-30 and 2026-05-31, VHT went from behaving like 37.3 equally weighted positions to 23 — 38% fewer, while its top ten went from 42.75% to 51.95% of net assets. Read across the funds on the concentration-over-time table.

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

Measured against every other fund on this site, from the same filings. Combined effective holdings is how the pair behaves held in equal size.

The 15 largest of 403 positions in VHT's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: VHT.csv.gz.

Monthly total returns from Item B.5 of VHT's own filings, 81 months on record. Not computed here and not from a price feed.

Cross-checked against a series computed separately from prices: median difference 0.05 percentage points over 81 months, which is roughly the distributions. Every month with the filing it came from: VHT.json · all funds.

The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-05-31, $25m was out to 10 borrowers, 0.13% of net assets. The largest, BARCLAYS BANK PLC, held 40.8% of it.

Cash collateral reported against the loan: 0.16% of net assets, 121.9% of the amount lent. That is a floor on the collateral, not the whole of it — collateral the fund does not hold as a position is not in this filing, so a figure under 100% is not evidence of under-collateralisation. How that figure behaves across all funds. Every quarter VHT has filed, with each borrower: VHT.json · all funds.

408 positions became 399: 3 added (0.0% of the fund at the later date), 12 dropped (0.8% at the earlier date). Half the sum of all weight changes, a turnover proxy: 6.9%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of VHT compared this way, as a feed: changes.xml · all funds: filings received.

New: agilon health Inc (0.02%), First Tracks Biotherapeutics Inc (0.00%), Hologic Inc (0.00%). Gone: Exact Sciences Corp (0.29%), Hologic Inc (0.25%), Amicus Therapeutics Inc (0.06%), Arcellx Inc (0.05%), Terns Pharmaceuticals Inc (0.04%), Soleno Therapeutics Inc (0.03%).

99.78% equity, 0.22% short-term investment as filed; 100.0% carried at a quoted market price (fair-value level 1). Categories and levels are the filer's; what a low level-1 share does and does not mean is in the measure's page.

A position count cannot describe a fund that uses derivatives, because a swap is filed at its unrealised gain, not its exposure. These are the notionals the fund itself reported, against net assets of $18.99B. Notional of an interest-rate or currency swap is not equity exposure.

Financing leg as filed: the fund pays OBFR01 + 0% on $35M of long swap notional . Issuers fill the spread field differently (some file the all-in rate), so compare within an issuer, not across.

Full detail for every fund that files derivatives: leverage.json (CC BY 4.0).

Every measured equity fund lined up by how many holdings it behaves like; these sit either side of VHT (23). Same filings, same arithmetic. Position in this list says nothing about which fund is better.

• XLV vs VHT: Two Ways to Own Healthcare — Concentration, Fees, and Defensive Behavior

  XLV holds roughly 60 large-cap S&P 500 healthcare names; VHT holds around 400 across the full U.S. cap spectrum — the same sector, two different portfolios....

  17 Jul 2026 9 min ETF Analysis